Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Capital Expenditures: 2021-2025

Historic Capital Expenditures for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $4.6 million.

  • Roivant Sciences' Capital Expenditures rose 687.95% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 409.85%. This contributed to the annual value of $4.6 million for FY2025, which is 232.78% up from last year.
  • Roivant Sciences' Capital Expenditures amounted to $4.6 million in FY2025, which was up 232.78% from $1.4 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Capital Expenditures registered a high of $17.4 million during FY2022, and its lowest value of $1.4 million during FY2024.
  • In the last 3 years, Roivant Sciences' Capital Expenditures had a median value of $4.6 million in 2025 and averaged $6.2 million.
  • Per our database at Business Quant, Roivant Sciences' Capital Expenditures tumbled by 89.11% in 2024 and then soared by 232.78% in 2025.
  • Roivant Sciences' Capital Expenditures (Yearly) stood at $5.8 million in 2021, then surged by 200.31% to $17.4 million in 2022, then declined by 27.22% to $12.7 million in 2023, then slumped by 89.11% to $1.4 million in 2024, then surged by 232.78% to $4.6 million in 2025.